Chimerix Inc (NASDAQ:CMRX)

20.49
Data as of Apr 17
 +1.25 / +6.50%
Today’s Change
12.96
Today|||52-Week Range
27.69
+35.61%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$554.5M

Company Description

Chimerix, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel, oral antiviral therapeutics designed to transform patient care in areas of unmet medical need. Its proprietary lipid technology has given rise to two clinical-stage lipid acyclic nucleoside phosphonates, CMX001 and CMX157, which have demonstrated the potential for enhanced activity and safety in convenient, orally administered dosing regimens. Chimerix's lead product candidate, CMX001, is a broad spectrum antiviral against double-stranded DNA viruses. CMX157, is an oral nucleotide compound in Phase 1 development for the treatment of HIV infection. The company was founded in April 2000 and is headquartered in Durham, NC.

Contact Information

Chimerix, Inc.
2505 Meridian Parkway
Durham North Carolina 27713
P:(919) 806-1074
Investor Relations:

Employees

Shareholders

Other institutional9.64%
Individual stakeholders35.32%
Mutual fund holders27.34%

Top Executives

M. Michelle BerreyPresident, Chief Executive & Medical Officer
Timothy W. TrostChief Financial Officer, Secretary & Senior VP
Hervé Momméja-MarinVice President-Clinical Research
Linda M. RichardsonChief Commercial Officer
Michael D. RogersChief Development Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.